Related Experiment Videos
Adiponectin--its role in metabolism and beyond
1Clinical Nutrition and Metabolism Section, NIDDK, NIH, Phoenix, Arizona 85016, USA.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|October 18, 2002
Summary
Adiponectin, a protein from fat tissue, improves insulin sensitivity and glucose tolerance. Low levels are linked to obesity and type 2 diabetes, suggesting it as a drug target.
Area of Science:
- Metabolic research
- Endocrinology
- Adipose tissue biology
Background:
- Adiponectin is an adipose tissue-derived protein (adipocytokine) with significant metabolic roles.
- Its expression is regulated by various factors including insulin-like growth factor-1, tumor necrosis factor-alpha, and peroxisome proliferator-activated receptor (PPAR)-gamma activators.
- Adiponectin plays a crucial role in regulating insulin sensitivity and glucose metabolism.
Purpose of the Study:
- To investigate the metabolic effects of adiponectin.
- To explore the relationship between adiponectin, obesity, insulin resistance, and type 2 diabetes.
- To assess the potential of adiponectin as a therapeutic target for metabolic disorders.
Main Methods:
- Review of existing literature on adiponectin's function and regulation.
- Analysis of animal models demonstrating the effects of recombinant adiponectin.
- Examination of human studies correlating plasma adiponectin levels with obesity and insulin sensitivity.
- Investigation of genetic associations between adiponectin and PPAR-gamma genes with metabolic diseases.
Main Results:
- Recombinant adiponectin enhances insulin sensitivity and glucose tolerance in animal models, primarily by suppressing glucose production.
- Human plasma adiponectin concentrations are inversely related to obesity and positively associated with insulin sensitivity.
- Low adiponectin levels may contribute to insulin resistance in obesity.
- Genetic variants in adiponectin and PPAR-gamma genes are linked to hypoadiponectinemia, insulin resistance, and type 2 diabetes.
Conclusions:
- Adiponectin is a key regulator of whole-body insulin sensitivity and glucose tolerance.
- Hypoadiponectinemia, often associated with obesity, is implicated in insulin resistance and type 2 diabetes.
- Adiponectin levels may reflect in vivo PPAR-gamma activity.
- Modulating adiponectin levels or activity presents a promising therapeutic strategy for improving insulin sensitivity and managing type 2 diabetes.